Qualigen Therapeutics Price Prediction
| QLGNDelisted Stock | USD 3.20 0.22 7.38% |
Momentum 38
Sell Extended
Oversold | Overbought |
Using Qualigen Therapeutics hype-based prediction, you can estimate the value of Qualigen Therapeutics from the perspective of Qualigen Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Qualigen Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Qualigen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Qualigen Therapeutics after-hype prediction price | USD 2.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Qualigen |
Qualigen Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Qualigen Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Qualigen Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Qualigen Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Qualigen Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Qualigen Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Qualigen Therapeutics' historical news coverage. Qualigen Therapeutics' after-hype downside and upside margins for the prediction period are 0.15 and 8.81, respectively. We have considered Qualigen Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Qualigen Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Qualigen Therapeutics is based on 3 months time horizon.
Qualigen Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Qualigen Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Qualigen Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Qualigen Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.86 | 5.85 | 0.24 | 0.30 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.20 | 2.96 | 7.50 |
|
Qualigen Therapeutics Hype Timeline
Qualigen Therapeutics is at this time traded for 3.20. The entity has historical hype elasticity of -0.24, and average elasticity to hype of competition of -0.3. Qualigen is forecasted to decline in value after the next headline, with the price expected to drop to 2.96. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -7.5%, whereas the daily expected return is at this time at 0.86%. The volatility of related hype on Qualigen Therapeutics is about 1671.43%, with the expected price after the next announcement by competition of 2.90. The company has price-to-book ratio of 0.41. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Qualigen Therapeutics recorded earning per share (EPS) of 6.32. The entity last dividend was issued on the 26th of May 2020. The firm had 1:50 split on the 5th of November 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.Qualigen Therapeutics Related Hype Analysis
Having access to credible news sources related to Qualigen Therapeutics' direct competition is more important than ever and may enhance your ability to predict Qualigen Therapeutics' future price movements. Getting to know how Qualigen Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Qualigen Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SNGX | Soligenix | (0.02) | 10 per month | 0.00 | (0.06) | 7.03 | (6.25) | 30.10 | |
| OGEN | Oragenics | (0.02) | 8 per month | 0.00 | (0.20) | 4.55 | (7.53) | 19.90 | |
| TTNP | Titan Pharmaceuticals | (0.08) | 25 per month | 5.38 | 0.03 | 9.38 | (8.08) | 30.41 | |
| CANF | Can Fite Biopharma | (0.05) | 8 per month | 0.00 | (0.15) | 10.40 | (8.59) | 38.42 | |
| XBIO | Xenetic Biosciences | 0.02 | 36 per month | 0.00 | (0.14) | 4.76 | (6.84) | 18.79 | |
| KZIA | Kazia Therapeutics Ltd | (2.70) | 7 per month | 9.69 | 0.06 | 14.69 | (18.36) | 78.79 | |
| ENSC | Ensysce Biosciences | (0.08) | 8 per month | 0.00 | (0.31) | 5.94 | (10.78) | 23.86 | |
| CNSP | CNS Pharmaceuticals | 0.01 | 8 per month | 0.00 | (0.11) | 7.22 | (7.57) | 26.44 | |
| CMND | Clearmind Medicine Common | (0.22) | 9 per month | 0.00 | (0.34) | 11.60 | (21.84) | 56.34 | |
| KALA | Kala Pharmaceuticals | (0.36) | 9 per month | 0.00 | (0.04) | 12.28 | (11.76) | 59.48 |
Qualigen Therapeutics Additional Predictive Modules
Most predictive techniques to examine Qualigen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Qualigen using various technical indicators. When you analyze Qualigen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Qualigen Therapeutics Predictive Indicators
The successful prediction of Qualigen Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Qualigen Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Qualigen Therapeutics based on analysis of Qualigen Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Qualigen Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Qualigen Therapeutics's related companies.
Pair Trading with Qualigen Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qualigen Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Qualigen Stock
| 0.54 | GE | GE Aerospace | PairCorr |
| 0.44 | DIS | Walt Disney | PairCorr |
| 0.41 | PG | Procter Gamble | PairCorr |
| 0.41 | MSFT | Microsoft Earnings Call Tomorrow | PairCorr |
| 0.4 | SIGL | Signal Advance | PairCorr |
| 0.34 | CVX | Chevron Corp Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Qualigen Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qualigen Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qualigen Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qualigen Therapeutics to buy it.
The correlation of Qualigen Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qualigen Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qualigen Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qualigen Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Qualigen Stock
If you are still planning to invest in Qualigen Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qualigen Therapeutics' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |